A look ahead: Medical breakthrough discovered at St. Jude could - WDAM - TV 7 - News, Weather and Sports

Medical breakthrough at St. Jude could change lives for sickle cell patients

Posted: Updated:
Three-year-old Nyla and 6-year-old Blake, have sickle cell. Three-year-old Nyla and 6-year-old Blake, have sickle cell.
"It can cripple [my children]. They can not walk if it's in their leg area. They can't walk on it," said mother Angela Ballentine. "It can cripple [my children]. They can not walk if it's in their leg area. They can't walk on it," said mother Angela Ballentine.
Dr. Winfred Wang, the head of Hematology at St. Jude led the drug trial from Memphis. Dr. Winfred Wang, the head of Hematology at St. Jude led the drug trial from Memphis.
From ages nine to 18 months, 193 children in 13 hositals took part; 20 were St. Jude patients. Doctors gave half of the patients Hydroxyurea while the other half took a placebo. From ages nine to 18 months, 193 children in 13 hositals took part; 20 were St. Jude patients. Doctors gave half of the patients Hydroxyurea while the other half took a placebo.
  • Most ReadMost Popular StoriesMore>>

  • Mississippi unemployment highest in nation

    Mississippi unemployment highest in nation

    Wednesday, August 20 2014 5:43 PM EDT2014-08-20 21:43:48 GMT
    June 2014, Labor Market Information Dept.June 2014, Labor Market Information Dept.
    The most recent numbers have been released and once again, Mississippi's unemployment rate has ranked highest in the nation. The national average, according to the U.S. Labor Department, is 6.2%, whileMore >>
    The most recent numbers have been released and once again, Mississippi's unemployment rate has ranked highest in the nation. The national average, according to the U.S. Labor Department, is 6.2%, whileMore >>
  • Police still investigating whether Vicksburg incident was an abduction

    Police find 2-month-old child allegedly abducted in Vicksburg

    Wednesday, August 20 2014 1:52 PM EDT2014-08-20 17:52:07 GMT
    According to law enforcement sources, a 2-month-old baby in Vicksburg has been found, along with the man who is accused of abducting the child.  We are told that suspect kicked in the door at 400 BayouMore >>
    The mother of the child reported that her ex-boyfriend, Kevin Buck, entered her house and took the child without her permission.
    More >>
  • Tropical wave development possible, not likely

    Wednesday, August 20 2014 3:19 PM EDT2014-08-20 19:19:08 GMT
    There is currently a lot of misinformation (and fear) floating around the Internet about the development of a hurricane in the Atlantic Ocean threatening the Gulf Coast of the United States late next week.More >>
    There is currently a lot of misinformation (and fear) floating around the Internet about the development of a hurricane in the Atlantic Ocean threatening the Gulf Coast of the United States late next week.More >>

(WMC-TV) - Doctors at St. Jude Children's Research Hospital discovered a medical breakthrough in a decades-old drug used to treat adults with sickle cell anemia. In a clinical trial, the drug Hydroxyurea shows incredible results in young children also suffering the disease.

"It can cripple [my children]. They cannot walk if it's in their leg area. They can't walk on it," said mother Angela Ballentine. "They have not had a crisis since they've been on this drug."

Her children, 3-year-old Nyla and 6-year-old Blake, have sickle cell; the blood disorder turns normal red blood cells into a sickle shape making blood flow difficult. It affects one in every 500 African-Americans.

The extreme pain forces the family into many hospital visits.

"We could be there every weekend or once a month or twice a month. Often," said Angela. "Sometimes it's a blood transfusion. Most of the time it's just fluids and antibiotics."

Dr. Winfred Wang, the head of Hematology at St. Jude led the drug trial from Memphis.

From ages nine to 18 months, 193 children in 13 hospitals took part; 20 were St. Jude patients. Doctors gave half of the patients Hydroxyurea while the other half took a placebo.

"About a 50 percent decrease in crisis," said Dr. Wang."Although we don't know the full long-term affects of hydroxyurea, we have not seen anything dangerous. We do know there are substantial long-term benefits."

According to Wang, increasing evidence proves Hydroxyurea prolongs life in young patients. Angela knows the drug will be a life-long commitment for her kids.

"They have to take it every day, probably for the rest of their lives, but the alternative is being sick. So I'd rather for them to take the drug than to have ongoing pain," she said.

"Absolutely, it has changed our lives."

The trial could change lives around the world. Currently, researchers seek full approval from the Food and Drug Administration.

For the latest information on sickle cell research at St. Jude, click here.

Get the latest from Action News 5 anytime: iPhone | iPad | Android | SMS Alerts | Email Alerts | Facebook | Twitter | Instagram

Copyright 2014 WMC-TV. All rights reserved.